Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Jaguar Health, Inc. | 11,911 | reported | 11 Dec 2025 | tx 23+501,824−15,216 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Dec 2025 | GRANT_AWARD | Jaguar Health, Inc. | 11,740 | 0.00 USD | |
| 11 Dec 2025 | GRANT_AWARD | Jaguar Health, Inc. | 11,740 | 0.00 USD | deriv |
| 31 Mar 2025 | PURCHASE | Jaguar Health, Inc. | 5,400 | 30000.00 USD | derivfirst after silence |
| 31 Mar 2025 | PURCHASE | Jaguar Health, Inc. | 5,400 | — | deriv |
| 08 Oct 2024 | GRANT_AWARD | Jaguar Health, Inc. | 4,280 | 0.00 USD | |
| 08 Oct 2024 | GRANT_AWARD | Jaguar Health, Inc. | 34,240 | 0.00 USD | deriv |
| 17 May 2024 | EXERCISE | Jaguar Health, Inc. | 431 | — | |
| 17 May 2024 | EXERCISE | Jaguar Health, Inc. | 431 | 0.00 USD | deriv |
| 05 Apr 2024 | EXERCISE | Jaguar Health, Inc. | 60 | — | |
| 05 Apr 2024 | GRANT_AWARD | Jaguar Health, Inc. | 60 | 0.00 USD | deriv |
| 14 Aug 2023 | GRANT_AWARD | Jaguar Health, Inc. | 142,088 | 0.00 USD | |
| 17 May 2023 | EXERCISE | Jaguar Health, Inc. | 431 | — | |
| 17 May 2023 | EXERCISE | Jaguar Health, Inc. | 431 | 0.00 USD | deriv |
| 05 Apr 2023 | EXERCISE | Jaguar Health, Inc. | 60 | — | |
| 05 Apr 2023 | GRANT_AWARD | Jaguar Health, Inc. | 60 | 0.00 USD | deriv |
| 27 Dec 2022 | OTHER | Jaguar Health, Inc. | 14,294 | 0.00 USD | deriv |
| 05 Apr 2022 | EXERCISE | Jaguar Health, Inc. | 4,513 | — | |
| 05 Apr 2022 | GRANT_AWARD | Jaguar Health, Inc. | 4,513 | 0.00 USD | deriv |
| 13 Sept 2021 | PURCHASE | Jaguar Health, Inc. | 7,968 | 2.51 USD | |
| 28 Mar 2022 | GRANT_AWARD | Jaguar Health, Inc. | 97,025 | 0.00 USD | deriv |
| 05 Apr 2021 | GRANT_AWARD | Jaguar Health, Inc. | 40,625 | 0.00 USD | deriv |
| 05 Apr 2021 | GRANT_AWARD | Jaguar Health, Inc. | 81,250 | 0.00 USD | deriv |
| 20 Mar 2020 | GRANT_AWARD | Jaguar Health, Inc. | 50,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 31 Mar 2025.